160 related articles for article (PubMed ID: 23732769)
1. Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer.
Yoshida K; Takenaka T; Akiyama H; Yamazaki H; Yoshida M; Masui K; Kotsuma T; Baek S; Uesugi Y; Shimbo T; Yoshikawa N; Arika T; Koretsune Y; Yoshioka Y; Narumi Y; Tanaka E
J Radiat Res; 2014 Jan; 55(1):154-61. PubMed ID: 23732769
[TBL] [Abstract][Full Text] [Related]
2. A 3D-printed patient-specific applicator guide for use in high-dose-rate interstitial brachytherapy for tongue cancer: a phantom study.
Choi CH; Kim JI; Park JM
Phys Med Biol; 2019 Jul; 64(13):135002. PubMed ID: 31170698
[TBL] [Abstract][Full Text] [Related]
3. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
[TBL] [Abstract][Full Text] [Related]
5. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dose-volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer.
Takenaka T; Yoshida K; Tachiiri S; Yamazaki H; Aramoto K; Furuya S; Yoshida M; Ban C; Tanaka E; Honda K
J Radiat Res; 2012 Sep; 53(5):791-7. PubMed ID: 22843369
[TBL] [Abstract][Full Text] [Related]
7. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
8. Interfractional change of high-risk CTV D90 during image-guided brachytherapy for uterine cervical cancer.
Ohkubo Y; Ohno T; Noda SE; Kubo N; Nakagawa A; Kawahara M; Abe T; Kiyohara H; Wakatsuki M; Nakano T
J Radiat Res; 2013 Nov; 54(6):1138-45. PubMed ID: 23732770
[TBL] [Abstract][Full Text] [Related]
9. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
10. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
[TBL] [Abstract][Full Text] [Related]
11. Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size?
Yoshida K; Yamazaki H; Kotsuma T; Takenaka T; Ueda MM; Miyake S; Tsujimoto Y; Masui K; Yoshioka Y; Sumida I; Uesugi Y; Shimbo T; Yoshikawa N; Yoshioka H; Tanaka E; Narumi Y
Brachytherapy; 2016; 15(1):57-64. PubMed ID: 26612700
[TBL] [Abstract][Full Text] [Related]
12. Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning.
Wang B; Kwon A; Zhu Y; Yeo I; Henson CF
Brachytherapy; 2009; 8(2):240-247. PubMed ID: 19230789
[TBL] [Abstract][Full Text] [Related]
13. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis.
Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589
[TBL] [Abstract][Full Text] [Related]
14. Implications for dosimetric changes when introducing MR-guided brachytherapy for small volume cervix cancer: a comparison of CT and MR-based treatments in a single centre.
Dempsey C; Govindarajulu G; Sridharan S; Capp A; O'Brien P
Australas Phys Eng Sci Med; 2014 Dec; 37(4):705-12. PubMed ID: 25344886
[TBL] [Abstract][Full Text] [Related]
15. Image-guided adaptive brachytherapy in cervical cancer: Patterns of relapse by brachytherapy planning parameters.
Chargari C; Mazeron R; Escande A; Maroun P; Dumas I; Martinetti F; Tafo-Guemnie A; Deutsch E; Morice P; Haie-Meder C
Brachytherapy; 2016; 15(4):456-462. PubMed ID: 27180129
[TBL] [Abstract][Full Text] [Related]
16. A novel applicator design for intracavitary brachytherapy of the nasopharynx: Simulated reconstruction, image-guided adaptive brachytherapy planning, and dosimetry.
Bacorro WR; Agas RAF; Cabrera SMR; Bojador MR; Sogono PG; Mejia MBA; Sy Ortin TT
Brachytherapy; 2018; 17(4):709-717. PubMed ID: 29759328
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume parameters and clinical outcome of CT-guided free-hand high-dose-rate interstitial brachytherapy for cervical cancer.
Wang Y; Ye WJ; Du LH; Li AJ; Ren YF; Cao XP
Chin J Cancer; 2012 Dec; 31(12):598-604. PubMed ID: 22640625
[TBL] [Abstract][Full Text] [Related]
18. Daily CT measurement of needle applicator displacement during multifractionated high-dose-rate interstitial brachytherapy for postoperative recurrent uterine cancer.
Yoshida K; Ueda M; Takenaka T; Yamazaki H; Kotsuma T; Aramoto K; Miyake S; Koretsune Y; Ban C; Tanaka E
J Radiat Res; 2012; 53(2):295-300. PubMed ID: 22240942
[TBL] [Abstract][Full Text] [Related]
19. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
[TBL] [Abstract][Full Text] [Related]
20. Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer.
Ju SG; Huh SJ; Shin JS; Park W; Nam H; Bae S; Oh D; Hong CS; Kim JS; Han Y; Choi DH
J Radiat Res; 2013 Mar; 54(2):349-56. PubMed ID: 23104899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
